Navigation Links
Amilpar - Distribution of Interest on Capital Stock
Date:12/29/2009

RIO DE JANEIRO, Dec. 29 /PRNewswire-FirstCall/ -- Amilpar (Bovespa: AMIL3; Bloomberg: AMIL3 BZ and APAR < GO >; Reuters: AMIL3.SA), the largest managed care organization in Brazil, informs its Shareholders that the Board of Directors of the Company, in a meeting held today, approved the payment of Interest on Capital Stock in the gross amount of R$ 0.0168 per common share, corresponding to the total amount of R$ 6.0 million. The payment will be made on April 30, 2010, based on shareholders' position as of December 29, 2009.

Except for exempt shareholders under applicable legislation, the payment of Interest on Capital Stock will have deducted 15% (fifteen per cent) for Income Tax, resulting in net Interest of R$ 0.0143 per common share. The shareholders exempt from Tax Withholding must confirm this status by mailing the corresponding documents to the following address no later than January 5, 2010:

    Amilpar - Relacoes com Investidores (Investor Relations)
    Av. das Americas, 4,200 - Bl. 3 - 4th Floor - Barra da Tijuca
    Rio de Janeiro - RJ - Postal Code 22640-907

The Company will consider the shareholder not tax-exempt if the above- mentioned documents are not received by the aforementioned date.

The Interest on Capital Stock will be attributed to the minimum mandatory dividend relative to the fiscal year ending December 31, 2009 for its net amount, after the deduction of Income Tax, as per Paragraph 7, article 9 of the Brazilian Corporate Law # 9,249/95, and in item V of CVM Deliberation 207/96.

Please note that shares acquired on or after December 30, 2009 will be traded Ex-Interest on Capital Stock.

To access the Notice to Shareholders, visit our website at www.amilpar.com.br/ir

    IR Contact
    Erwin Kleuser
    Investor Relations Officer
    Phone: +55 (21) 3805-1155
    invest@amil.com.br
    www.amilpar.com.br/ir

SOURCE Amilpar


'/>"/>
SOURCE Amilpar
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Amilpar - Relevant Fact
2. Amilpar - Press Release - Commercial Papers
3. Amilpar - Relevant Fact - Public Offer
4. Amilpar - Revenues Grow 8% and Net Income Improves 28% in 3Q09
5. Amilpar - Operating Revenues Grew 9% in the Second Quarter and 11% in the First Half of 2009
6. Amilpar - Revenue Increases 13.4% and Medical Loss Ratio Falls in the First Quarter 2009
7. Amilpar - Revenues Increase by 26.5% and Adjusted Net Income Climbs 28.7% in 2008
8. Amilpar - Notice to Shareholders - Distribution of Interest on Capital Stock
9. Amilpar Revenues Grow 28% in the First 9 Months of 2008 and 4.5% Over Previous Quarter
10. Amilpar Revenues Increase by 32% and EBITDA Doubles in 2007
11. Grubb & Ellis Healthcare REIT II Declares Initial Distribution
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... (PRWEB) , ... July 21, 2017 , ... ... management assistance and financial planning services to families and business owners in northern ... event that promises to provide support to area adults with developmental challenges. , ...
(Date:7/21/2017)... , ... July 21, 2017 , ... ... and Theater of Witness , was awarded a $300,000 grant from ... program which fosters empathy, comfort with ambiguity and the recognition of one’s own ...
(Date:7/21/2017)... ... ... Overseer at The House of Yahweh in Abilene, Texas, has written a new post this ... world leaders to be more open about positive changes. Yisrayl says the use of force ... peaceful and positive way to solve all; yes, all issues, and he is ready to ...
(Date:7/21/2017)... , ... July 21, 2017 , ... ... Nature’s Tears® EyeMist®, the signature product of her research center at Bio-Logic Aqua ... world’s largest population and the greatest number of sufferers of blindness. “We think ...
(Date:7/21/2017)... ... July 21, 2017 , ... How physicians and athletic trainers ... say researchers presenting their work at the American Orthopaedic Society for Sports ... evaluating the patterns of change in concussion symptom presentation, diagnostic tools used and ...
Breaking Medicine News(10 mins):
(Date:7/10/2017)... July 10, 2017 The Institute for In ... is the recipient of a VITROCELL® inhalation exposure system ... Science Consortium. The device, which is designed to replace ... human lung cells to airborne test materials in an ... the VITROCELL® system for testing combustible tobacco products, as ...
(Date:7/6/2017)... nutrition division of Diplomat Specialty Infusion Group, is celebrating a decade of ... To celebrate its anniversary, ThriveRx recently launched a redesigned website at ... organization to create the best user experience for consumers and health care ... Diplomat Pharmacy ... "We,ve made several great strides throughout the past 10 ...
(Date:7/5/2017)... July 5, 2017   BioLife Solutions , Inc. ... and marketer of proprietary clinical grade cell and tissue ... media ("BioLife"), today announced that it has reached an ... and largest shareholder, to modify its existing credit facility ... the modification, WAVI agreed to exchange its existing $4.25 ...
Breaking Medicine Technology: